Tuesday, September 16, 2025
HomeIndustries

Industries

Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces the first patient dosed in the Phase II clinical trial of...

HotSpot Therapeutics Presents Pre-Clinical Data on CBL-B Program at American Association

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of first- and best-in-class small molecule allosteric therapies targeting regulatory sites on proteins...

Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, announced the...

Joint Statement from CMS Administrator Chiquita Brooks-LaSure and FDA Commissioner Robert M. Califf, M.D., on Ensuring Access to Safe and Effective Treatments

Ensuring the availability of innovative interventions for people is a shared priority for both the Centers for Medicaid & Medicare Services (CMS) and the...

Kubota Announces Grand Opening of R&D Center, Expanding North America-Based Innovation

Kubota North America Corporation (KNA), the parent company for Kubota Tractor Corporation (KTC) and Kubota Manufacturing of America (KMA), and Kubota Canada Ltd. (KCL)...
0FansLike
0FollowersFollow
spot_img

Hot Topics